腹腔镜辅助下阴式广泛全子宫切除联合淋巴结切除术治疗早期宫颈癌的疗效观察

Efficacy of Laparoscopic Assisted Vaginal Hysterectomy Combined with Lymph Node Curative Resection in the Treatment of Early Cervical Cancer

目的探讨腹腔镜辅助下阴式广泛全子宫切除联合淋巴结切除术治疗早期宫颈癌的疗效。方法入组148例早期宫颈癌患者,根据患者及家属意愿分为观察组和对照组,每组74例,观察组实施腹腔镜辅助下阴式广泛全子宫切除联合淋巴结切除术,对照组为传统开腹手术,比较分析2组术中及术后情况。结果与对照组比较,观察组手术时间、出血量均显著减少,而淋巴结切除数目增加(P均<0.05)。观察组利用镇痛药例数少于对照组,且肛门排气时间、恢复正常体温时间、盆腔引流时间较对照组均明显缩短(P均<0.05)。2组复发率、死亡率比较差异均无统计学意义(P均>0.05)。观察组并发症发生率明显低于对照组(P<0.05)。结论腹腔镜辅助下阴式广泛全子宫切除联合淋巴结切除术安全性较高,相比传统开腹手术治疗早期宫颈癌存在明显优势,可明显减少术后并发症,患者术后恢复良好,治疗效果较为理想,可以作为治疗早期宫颈癌的首选手术方案。

Objective To investigate the efficacy of laparoscopic assisted vaginal hysterectomy combined with lymph node excision in the treatment of early cervical cancer. Methods The 148 patients with early cervical cancer were divided into the observation group and the control group according to the wishes of patients and their families, each group of 74 patients, 74 patients of the observation group received laparoscopic assisted vaginal hysterectomy combined with lymph node resection, 74 patients of the control group received traditional open surgery, the operation efficacy were compared between the two groups. Results Compared with the control group, the operation time and bleeding volume were less, and the number of removed lymph nodes was more in the observation group （ P 〈 0.05 ）. The patients with analgesics, anal exhaust time, body temperature returned to normal time, pelvic drainage time in the observation group was shorter than those in the control group （ P 〈 0.05 ）. The recurrence rate and mortality rate of the two groups were not statistically significant（ P 〉 0.05 ）. The complications incidence of the observation group was lower than that of the control group （P 〈 0.05）. Conclusion laparoscopic assisted vaginal hysterectomy combined with extensive lymph node excision is safe, and can greatly reduce the rate of postoperative complications, postoperative recovery is good, ideal treatment effect, can be used as a reliable treatment for early cervical cancer.